{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:21:51Z","timestamp":1787908911589,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05595-x","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:46:08Z","timestamp":1781858768000},"page":"3343-3359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CCL3 promotes oxaliplatin resistance in gastric cancer via CCR5-mediated tumor cell survival and macrophage M2 polarization"],"prefix":"10.1007","volume":"481","author":[{"given":"Xun","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"5595_CR1","doi-asserted-by":"publisher","first-page":"103841","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ Lopez","year":"2023","unstructured":"Lopez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM et al (2023) Characteristics of gastric cancer around the world. Crit Rev Oncol\/Hematol 181:103841","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"3","key":"5595_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.21657","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD (2021) Current treatment and recent progress in gastric cancer. Cancer J Clin 71(3):264\u2013279","journal-title":"Cancer J Clin"},{"issue":"3","key":"5595_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/cimb47030172","volume":"47","author":"T Ye","year":"2025","unstructured":"Ye T, Wu C, Na J, Liu X, Huang Y (2025) Multi-Pathway Study for Oxaliplatin Resistance Reduction. Curr Issues Mol Biol 47(3):172","journal-title":"Curr Issues Mol Biol"},{"key":"5595_CR4","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S520603","author":"J Ren","year":"2025","unstructured":"Ren J, Song M, Ding D, Lan T, Li Y, Liang R et al (2025) Combined oxaliplatin with 5-fluorouracil for effective chemotherapy against gastric cancer in animal model. Int J Nanomed. https:\/\/doi.org\/10.2147\/IJN.S520603","journal-title":"Int J Nanomed"},{"issue":"1","key":"5595_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00384-024-04654-3","volume":"39","author":"H Wu","year":"2024","unstructured":"Wu H, Deng M, Xue D, Guo R, Zhang C, Gao J et al (2024) PD-1\/PD-L1 inhibitors for early and middle stage microsatellite high-instability and stable colorectal cancer: a review. Int J Colorectal Dis 39(1):83","journal-title":"Int J Colorectal Dis"},{"key":"5595_CR6","doi-asserted-by":"publisher","first-page":"1152934","DOI":"10.3389\/fphar.2023.1152934","volume":"14","author":"J Zhai","year":"2023","unstructured":"Zhai J, Gu X, Liu Y, Hu Y, Jiang Y, Zhang Z (2023) Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: an update review. Front Pharmacol 14:1152934","journal-title":"Front Pharmacol"},{"issue":"1","key":"5595_CR7","doi-asserted-by":"publisher","first-page":"2120676","DOI":"10.1080\/2162402X.2022.2120676","volume":"11","author":"R Barnestein","year":"2022","unstructured":"Barnestein R, Galland L, Kalfeist L, Ghiringhelli F, Ladoire S, Limagne E (2022) Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness. Oncoimmunology 11(1):2120676","journal-title":"Oncoimmunology"},{"issue":"19","key":"5595_CR8","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.3390\/cancers16193246","volume":"16","author":"J Korbecki","year":"2024","unstructured":"Korbecki J, Bosiacki M, Stasiak P, Snarski E, Brodowska A, Chlubek D et al (2024) Clinical aspects and significance of \u03b2-Chemokines, \u03b3-Chemokines, and \u03b4-Chemokines in molecular cancer processes in acute myeloid leukemia (AML) and myelodysplastic neoplasms (MDS). Cancers 16(19):3246","journal-title":"Cancers"},{"key":"5595_CR9","doi-asserted-by":"publisher","first-page":"1682294","DOI":"10.3389\/fimmu.2025.1682294","volume":"16","author":"H Feng","year":"2025","unstructured":"Feng H, Hu W, Liu Y, Xu X, Zhou P, Qu C et al (2025) Macrophages in ventricular remodeling and heart failure: orchestrators of inflammation and repair. Front Immunol 16:1682294","journal-title":"Front Immunol"},{"key":"5595_CR10","doi-asserted-by":"publisher","first-page":"109332","DOI":"10.1016\/j.intimp.2022.109332","volume":"113","author":"HW Jun","year":"2022","unstructured":"Jun HW, Lee HK, Na IH, Lee SJ, Kim K, Park G et al (2022) The role of CCL2, CCL7, ICAM-1, and VCAM-1 in interaction of endothelial cells and natural killer cells. Int Immunopharmacol 113:109332","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5595_CR11","doi-asserted-by":"publisher","first-page":"e011310","DOI":"10.1136\/jitc-2024-011310","volume":"13","author":"H Peng","year":"2025","unstructured":"Peng H, Pan Y, Sun Y, Wang X, Fan X, Wang Y et al (2025) Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis. J Immunother Cancer 13(6):e011310","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5595_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/cells10010075","volume":"10","author":"M Lagan\u00e0","year":"2021","unstructured":"Lagan\u00e0 M, Schlecht-Louf G, Bachelerie F (2021) The G protein-coupled receptor kinases (GRKs) in chemokine receptor-mediated immune cell migration: From molecular cues to physiopathology. Cells 10(1):75","journal-title":"Cells"},{"issue":"4","key":"5595_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40744-023-00554-0","volume":"10","author":"Y-L Yang","year":"2023","unstructured":"Yang Y-L, Li X-F, Song B, Wu S, Wu Y-Y, Huang C, Li J (2023) The role of CCL3 in the pathogenesis of rheumatoid arthritis. Rheumatol Ther 10(4):793\u2013808","journal-title":"Rheumatol Ther"},{"issue":"3","key":"5595_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5114\/pja.2023.131708","volume":"10","author":"G Harvanov\u00e1","year":"2023","unstructured":"Harvanov\u00e1 G, Durankov\u00e1 S, Bernasovsk\u00e1 J (2023) The role of cytokines and chemokines in the inflammatory response. Alergologia Polska-Polish J Allergol 10(3):210\u2013219","journal-title":"Alergologia Polska-Polish J Allergol"},{"issue":"5","key":"5595_CR15","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/cancers14051236","volume":"14","author":"R Li","year":"2022","unstructured":"Li R, Mukherjee MB, Lin J (2022) Coordinated regulation of myeloid-derived suppressor cells by cytokines and chemokines. Cancers 14(5):1236","journal-title":"Cancers"},{"issue":"3","key":"5595_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3892\/or.2020.7906","volume":"45","author":"D Xue","year":"2021","unstructured":"Xue D, Zheng Y, Wen J, Han J, Tuo H, Liu Y et al (2021) Role of chemokines in hepatocellular carcinoma (review). Oncol Rep 45(3):809\u201323","journal-title":"Oncol Rep"},{"issue":"7","key":"5595_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura T, Li C, Wang Y, Matsukawa A (2023) The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol 20(7):714\u2013738","journal-title":"Cell Mol Immunol"},{"key":"5595_CR18","doi-asserted-by":"publisher","first-page":"1706744","DOI":"10.3389\/fimmu.2025.1706744","volume":"16","author":"C Wang","year":"2025","unstructured":"Wang C, Fan X, Sun X, Xu Y, Sun Y, Liu J (2025) Tumor associated macrophages in gastric cancer dual roles in immune evasion and clinical implications for targeted therapy. Front Immunol 16:1706744","journal-title":"Front Immunol"},{"issue":"10","key":"5595_CR19","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/cells10102655","volume":"10","author":"I Navasardyan","year":"2021","unstructured":"Navasardyan I, Bonavida B (2021) Regulation of T cells in cancer by nitric oxide. Cells 10(10):2655","journal-title":"Cells"},{"issue":"24","key":"5595_CR20","doi-asserted-by":"publisher","first-page":"12056","DOI":"10.3390\/ijms262412056","volume":"26","author":"JH Kang","year":"2025","unstructured":"Kang JH, Kim JH, Gim JA, Lee MY (2025) iNOS in macrophage polarization: pharmacological and regulatory insights. Int J Mol Sci 26(24):12056","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5595_CR21","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.3390\/cancers14123006","volume":"14","author":"R Zitter","year":"2022","unstructured":"Zitter R, Chugh RM, Saha S (2022) Patient derived ex-vivo cancer models in drug development, personalized medicine, and radiotherapy. Cancers 14(12):3006","journal-title":"Cancers"},{"key":"5595_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/17410541.2025.2581557","author":"R Brandi","year":"2025","unstructured":"Brandi R, Palcau AC, Migliano E, Strano S, Blandino G (2025) Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice. Pers Med. https:\/\/doi.org\/10.1080\/17410541.2025.2581557","journal-title":"Pers Med"},{"key":"5595_CR23","doi-asserted-by":"publisher","first-page":"114751","DOI":"10.1016\/j.biopha.2023.114751","volume":"163","author":"M Zu","year":"2023","unstructured":"Zu M, Hao X, Ning J, Zhou X, Gong Y, Lang Y et al (2023) Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing. Biomed Pharmacother 163:114751","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"5595_CR24","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1158\/1078-0432.CCR-21-4165","volume":"28","author":"TT Sepp\u00e4l\u00e4","year":"2022","unstructured":"Sepp\u00e4l\u00e4 TT, Zimmerman JW, Suri R, Zlomke H, Ivey GD, Szabolcs A et al (2022) Precision medicine in pancreatic cancer: patient-derived organoid pharmacotyping is a predictive biomarker of clinical treatment response. Clin Cancer Res 28(15):3296\u20133307","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5595_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s11605-022-05568-7","volume":"27","author":"C Yoon","year":"2023","unstructured":"Yoon C, Lu J, Kim B-J, Cho S-J, Kim JH, Moy RH et al (2023) Patient-derived organoids from locally advanced gastric adenocarcinomas can predict resistance to neoadjuvant chemotherapy. J Gastrointest Surg 27(4):666\u2013676","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"5595_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13046-025-03332-8","volume":"44","author":"P Li","year":"2025","unstructured":"Li P, Huang M, Li M, Li G, Ma Y, Zhao Y et al (2025) Combining molecular characteristics and therapeutic analysis of PDOs predict clinical responses and guide PDAC personalized treatment. J Exp Clin Cancer Res 44(1):72","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"5595_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/ijo.2024.5629","volume":"64","author":"J Xu","year":"2024","unstructured":"Xu J, Yu B, Wang F, Yang J (2024) Xenograft and organoid models in developing precision medicine for gastric cancer. Int J Oncol 64(4):41","journal-title":"Int J Oncol"},{"key":"5595_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41438-021-00616-w","author":"F Zhao","year":"2021","unstructured":"Zhao F, Maren NA, Kosentka PZ, Liao Y-Y, Lu H, Duduit JR et al (2021) An optimized protocol for stepwise optimization of real-time RT-PCR analysis. Hortic Res. https:\/\/doi.org\/10.1038\/s41438-021-00616-w","journal-title":"Hortic Res"},{"issue":"2","key":"5595_CR29","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1002\/mco2.147","volume":"3","author":"H Li","year":"2022","unstructured":"Li H, Wu M, Zhao X (2022) Role of chemokine systems in cancer and inflammatory diseases. MedComm 3(2):e147","journal-title":"MedComm"},{"issue":"42","key":"5595_CR30","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.2174\/0109298673315146240731100101","volume":"31","author":"Y Tian","year":"2024","unstructured":"Tian Y, Xie Y, Yi G, Wu F, Dang X, Bai F et al (2024) Prognostic value and therapeutic significance of CCL chemokines in gastric cancer. Curr Med Chem 31(42):7043\u201358","journal-title":"Curr Med Chem"},{"issue":"1","key":"5595_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1756-9966-29-37","volume":"29","author":"S He","year":"2010","unstructured":"He S, Wang L, Wu Y, Li D, Zhang Y (2010) CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo. J Exp Clin Cancer Res 29(1):37","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5595_CR32","doi-asserted-by":"publisher","first-page":"2387192","DOI":"10.1155\/2022\/2387192","volume":"2022","author":"X Ma","year":"2022","unstructured":"Ma X, Su J, Zhao S, He Y, Li S, Yang X et al (2022) CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6\/NF-\u03baB Molecular Pathway. Contrast Media Mol Imaging 2022(1):2387192","journal-title":"Contrast Media Mol Imaging"},{"issue":"5","key":"5595_CR33","doi-asserted-by":"publisher","first-page":"e003793","DOI":"10.1136\/jitc-2021-003793","volume":"10","author":"D Sheng","year":"2022","unstructured":"Sheng D, Ma W, Zhang R, Zhou L, Deng Q, Tu J et al (2022) Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization. J Immunother Cancer 10(5):e003793","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5595_CR34","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1186\/s12885-023-11434-9","volume":"23","author":"J Gao","year":"2023","unstructured":"Gao J, Lan J, Liao H, Yang F, Qiu P, Jin F et al (2023) Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges. BMC Cancer 23(1):1205","journal-title":"BMC Cancer"},{"issue":"4","key":"5595_CR35","doi-asserted-by":"publisher","first-page":"130566","DOI":"10.1016\/j.bbagen.2024.130566","volume":"1868","author":"J Xu","year":"2024","unstructured":"Xu J, Gong J, Li M, Kang Y, Ma J, Wang X et al (2024) Gastric cancer patient-derived organoids model for the therapeutic drug screening. Biochimica et Biophysica Acta (BBA)-General Subj 1868(4):130566","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subj"},{"issue":"16","key":"5595_CR36","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/cells13161312","volume":"13","author":"Z Yang","year":"2024","unstructured":"Yang Z, Yu J, Wong CC (2024) Gastrointestinal cancer patient derived organoids at the frontier of personalized medicine and drug screening. Cells 13(16):1312","journal-title":"Cells"},{"issue":"1","key":"5595_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","volume":"7","author":"X-Y Tang","year":"2022","unstructured":"Tang X-Y, Wu S, Wang D, Chu C, Hong Y, Tao M et al (2022) Human organoids in basic research and clinical applications. Signal Transduct Target therapy 7(1):168","journal-title":"Signal Transduct Target therapy"},{"issue":"3","key":"5595_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00018-022-04129-0","volume":"79","author":"H Li","year":"2022","unstructured":"Li H, Wang C, Lan L, Yan L, Li W, Evans I et al (2022) METTL3 promotes oxaliplatin resistance of gastric cancer CD133\u2009+\u2009stem cells by promoting PARP1 mRNA stability. Cell Mol Life Sci 79(3):135","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"5595_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli K, Pillarisetty VG, Kim TS (2022) Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther 29(1):10\u201321","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"5595_CR40","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","volume":"23","author":"R Qin","year":"2023","unstructured":"Qin R, Ren W, Ya G, Wang B, He J, Ren S et al (2023) Role of chemokines in the crosstalk between tumor and tumor-associated macrophages. Clin Exp Med 23(5):1359\u201373","journal-title":"Clin Exp Med"},{"issue":"1","key":"5595_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/tox.23675","volume":"38","author":"B Guan","year":"2023","unstructured":"Guan B, Li H, Yao J, Guo J, Yu F, Li G et al (2023) CCL3-CCR5 axis promotes cell migration and invasion of colon adenocarcinoma via Akt signaling pathway. Environ Toxicol 38(1):172\u2013184","journal-title":"Environ Toxicol"},{"key":"5595_CR42","unstructured":"Li L, Zhuocao Q, Xinyue Y, Yuanyuan W, Shengyu X, Fuyan L et al (2022) Combined effects of Huangqi and Ezhu with 5-flnorouracil on CXCL10\/CXCR3 and CCL3\/CCR5 expression in mice with CT26. WT orthotopic transplanted tumor. J Beijing Univ Traditional Chin Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05595-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:14:44Z","timestamp":1787908484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05595-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5595"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05595-x","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Ethics Committee of Minhang District Central Hospital, Shanghai (Approval No.: K2025-016).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}